ARDX
Ardelyx, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +20.0% ·
flujo de acciones +7.4% ·
nuevas posiciones netas +16.7%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | 0 | 123.14M | $629.29M | +7 | −7 |
| Q1 2026 | 100 | +3 | 138.17M | $826.25M | +6 | −3 |
| Q4 2025 | 95 | +1 | 146.57M | $854.46M | +1 | — |
| Q3 2025 | 18 | +1 | 90.83M | $500.46M | +1 | — |
| Q2 2025 | 14 | -2 | 85.87M | $336.62M | — | −2 |
| Q1 2025 | 13 | +1 | 41.26M | $202.59M | +2 | −1 |
| Q4 2024 | 12 | +2 | 28.08M | $142.38M | +3 | −1 |
| Q3 2024 | 9 | 0 | 14.54M | $100.22M | — | — |
| Q2 2024 | 9 | — | 13.39M | $99.20M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 11.59M | — | $58.78M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 5.51M | +0.4% | $27.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 5.51M | +0.4% | $27.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 2.96M | -26.1% | $15.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 2.49M | +12.8% | $12.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 2.49M | +12.8% | $12.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 1.47M | +9499.8% | $7.45M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 1.33M | Nuevo | $6.76M | 0.0% | New | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 1.14M | +16.0% | $5.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 650.00K | Nuevo | $3.30M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 545.25K | -11.8% | $2.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 545.25K | -11.8% | $2.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 545.25K | -11.8% | $2.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 162.82K | -84.8% | $826,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 114.82K | Nuevo | $582,132 | 0.0% | New | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 107.34K | -9.2% | $544,239 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 107.34K | -9.2% | $544,239 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 107.34K | -9.2% | $544,239 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 107.34K | -9.2% | $544,239 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $6.76M | 0.0% |
| Adage Capital Partners | $3.30M | 0.0% |
| Marshall Wace | $582,132 | 0.0% |
Posición cerrada
| Gotham Asset Management | $171,595 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 235 tenedores, 168.96M acciones, $997.54M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 15.01K acc. · $57,888
Officer, Director · 15.98K acc. · $61,618
Officer, Director · 8.41K acc. · $32,440
Officer, Director · 19.18K acc. · $73,968
Officer · 1.56K acc. · $6,009
Officer · 3.49K acc. · $13,445
Officer · 3.09K acc. · $11,914
Officer · 2.43K acc. · $9,372
Officer · 1.73K acc. · $6,688
Officer · 3.10K acc. · $11,972
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología